Synchronous Effect of Anesthetics on fMRI, EEG and Clinical Responses
Primary Purpose
Sedative Overdose
Status
Completed
Phase
Phase 1
Locations
Spain
Study Type
Interventional
Intervention
Propofol
Remifentanil
Sponsored by
About this trial
This is an interventional basic science trial for Sedative Overdose focused on measuring Propofol, remifentanil, hypnosis, EEG, fMRI,
Eligibility Criteria
Inclusion Criteria:
- Healthy adult volunteers (ASA 1 physical state) who agree to participate voluntarily in the study, previous information about it by the Principal Investigators (IP).
Exclusion Criteria:
- Psychological, psychiatric or neurological disorders. Consumption of drugs. Alterations cutaneous or anatomical cranial. Idiomatic or communication barrier. Allergy to propofol, remifentanil or to some of its excipients. Body mass index (BMI) <18 or> 30 kg / m2. Pregnancy. Airway or ventilation criteria hard. Absence of accompanying adult at the end of the study.
Sites / Locations
- Hospital del Mar
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Volunteers receiving propofol and remifentanil
Arm Description
Volunteers receive propofol to the loss of consciousness. Then they receive remifentanil during 12 min (pain stimuli in their finger also)
Outcomes
Primary Outcome Measures
Time and dose of propofol at loss of consciousness(LOC)
Volunteers stop tightening pneumatic pear. We register time and dose of propofol when the volunteer stops tightening pneumatic pear.
Register EEG and neuroimage during remifentanil administration.
After LOC, volunteers receive increasing doses of remifentanil and painful stimuli in the nail bed. If apnea, stop infusion remifentanil Volunteers receive increasing doses of remifentanil and painful stimuli in the nail bed. If apnea, stop infusion remifentanil. We registered time, dose, saturation and breathing frequency in every volunteer.
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03928366
Brief Title
Synchronous Effect of Anesthetics on fMRI, EEG and Clinical Responses
Official Title
Synchronous Effect of Anesthetics on fMRI, EEG and Clinical Responses. Development of a More Precise System for Monitoring Anesthetic Effect.
Study Type
Interventional
2. Study Status
Record Verification Date
September 2022
Overall Recruitment Status
Completed
Study Start Date
June 13, 2017 (Actual)
Primary Completion Date
January 9, 2019 (Actual)
Study Completion Date
June 30, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Parc de Salut Mar
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Background: The mechanisms of action of intravenous anesthetics are unclear and the current monitors have limitations.
This signifies difficulties when assessing the correct dosage due to the considerable inter-individual variability of the patients, particularly in the elderly or seriously ill. It is necessary to customize the administration of anesthetics as underdosage can lead to the patient awareness during aggressive procedures, and over-dosage can cause serious complications and even augment mortality.
Objective: To design a new monitoring system of the levels of consciousness and analgesia in anesthetized subjects which is more accurate than those currently employed. It will be based on the synchronic changes of functional magnetic resonance (fMR) and electroencephalograph (EEG) readings, and clinical responses.
Methodology: Thirty healthy volunteers will be given propofol and remifentanil in different combinations, and painful stimuli will be also applied. The principal variable will be fMR images obtained by echo-planar imaging sequences. Real time will be correlated with cortical connectivity maps, EEG parameters (qCON, qNOX), clinical responses, and concentrations of anesthetics measured by pharmacokinetic and pharmacodynamic models (TCI).
Detailed Description
Main goal:
Develop a system for monitoring the effect of anesthetics on consciousness and pain, based on synchronous changes in functional neuroimaging, EEG and clinical responses.
Secondary objectives:
Analyze the changes produced in the cortical connectivity map during the induction of anesthesia to understand the process of "advancement".
Know more accurately the neuronal circuits involved in propofol-induced sleep.
Study if the application of a known painful stimulus modifies in any way (clinical, EEG or by RMf) the LOC that has just been reached.
Establish propofol dosing guidelines adjusted to each patient, studying if they reach the LOC at "sedative" or "hypnotic" doses.
Establish remifentanil dosing guidelines, adjusted to each patient, studying the concentration of remifentanil to which the pain response in neuroimaging is inhibited (activation deactivation neuronal in fMRI).
Validate existing mathematical models in relation to plasma and brain concentrations of propofol and remifentanil.
Validate the value of clinical signs to predict whether a patient feels the painful stimulus received.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sedative Overdose
Keywords
Propofol, remifentanil, hypnosis, EEG, fMRI,
7. Study Design
Primary Purpose
Basic Science
Study Phase
Phase 1, Phase 2
Interventional Study Model
Sequential Assignment
Model Description
Volunteers receiving propofol and then remifentanil.
Masking
None (Open Label)
Allocation
N/A
Enrollment
30 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Volunteers receiving propofol and remifentanil
Arm Type
Experimental
Arm Description
Volunteers receive propofol to the loss of consciousness. Then they receive remifentanil during 12 min (pain stimuli in their finger also)
Intervention Type
Drug
Intervention Name(s)
Propofol
Other Intervention Name(s)
remifentanil
Intervention Description
sedation
Intervention Type
Drug
Intervention Name(s)
Remifentanil
Intervention Description
remifentanil
Primary Outcome Measure Information:
Title
Time and dose of propofol at loss of consciousness(LOC)
Description
Volunteers stop tightening pneumatic pear. We register time and dose of propofol when the volunteer stops tightening pneumatic pear.
Time Frame
10-15 min
Title
Register EEG and neuroimage during remifentanil administration.
Description
After LOC, volunteers receive increasing doses of remifentanil and painful stimuli in the nail bed. If apnea, stop infusion remifentanil Volunteers receive increasing doses of remifentanil and painful stimuli in the nail bed. If apnea, stop infusion remifentanil. We registered time, dose, saturation and breathing frequency in every volunteer.
Time Frame
10-15 min
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Healthy adult volunteers (ASA 1 physical state) who agree to participate voluntarily in the study, previous information about it by the Principal Investigators (IP).
Exclusion Criteria:
Psychological, psychiatric or neurological disorders. Consumption of drugs. Alterations cutaneous or anatomical cranial. Idiomatic or communication barrier. Allergy to propofol, remifentanil or to some of its excipients. Body mass index (BMI) <18 or> 30 kg / m2. Pregnancy. Airway or ventilation criteria hard. Absence of accompanying adult at the end of the study.
Facility Information:
Facility Name
Hospital del Mar
City
Barcelona
ZIP/Postal Code
08026
Country
Spain
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Participants will be introduced to the fMRI The head will be set to try to prevent involuntary movements associated with the LOC. Routine by pulse oximetry, non-invasive blood pressure and electrocardiogram (ECG). It will be administered oxygen at 2 liters / min by nasal cannula with capnography line and transcutaneous carbon dioxide will be monitored. Volunteers will not be premedicated.
EEG activity and fMRI images, as detailed in the section "Study variables". Each series of acquisitions will consist of a "resting state" (rs-fMRI), in which the subject will be asked to close their eyes and leave the mind ramble without further slogans, and also a series of tasks in which the participant will be exposed to a sequence of perceptive and nociceptive stimuli in order to objectify the effect of the drug on the nervous system central. The signal extracted from the RMf images will allow to study the dynamics of the metabolic changes and neurons in the brain with a temporal resolution.
IPD Sharing Time Frame
3 years
IPD Sharing Access Criteria
volunteers without exclusion criteria
Citations:
PubMed Identifier
29589170
Citation
Borrat X, Ubre M, Risco R, Gambus PL, Pedroso A, Iglesias A, Fernandez-Esparrach G, Gines A, Balust J, Martinez-Palli G. Computerized tests to evaluate recovery of cognitive function after deep sedation with propofol and remifentanil for colonoscopy. J Clin Monit Comput. 2019 Feb;33(1):107-113. doi: 10.1007/s10877-018-0134-3. Epub 2018 Mar 27.
Results Reference
background
Learn more about this trial
Synchronous Effect of Anesthetics on fMRI, EEG and Clinical Responses
We'll reach out to this number within 24 hrs